source
- Corxel Group to go public in US by merging with SPAC, targeting oral GLP-1 marketCorxel Group announced that it will become a publicly traded company in the United States through a merger with a special purpose acquisition company. The move follows a similar SPAC transaction by…
- NIH launches vaccine injury center that will also study long-term post-infection symptomsNIH announced a new center dedicated to investigating vaccine injuries. The center's mandate expands to include research on persistent symptoms after infections, such as long Covid. Officials sai…